{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[8,2,8,3],[9,2,9,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910777424803321"]
[null,null,"Titolo",null,"The children's vaccine initiative : continuing activities : a summary of two workshops held September 12-13 and October 25-26, 1994 / / Greg W. Pearson, editor ; Steering Committee on the Children's Vaccine Initiative: Continuing Activities, Division of Health Promotion and Disease Prevention, Institute of Medicine"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C. : , : National Academy Press, , 1995"]
[null,null,"Descrizione fisica",null,"1 online resource  (x, 55 pages)"]
[null,null,"Disciplina",null,"614.47"]
[null,null,"Soggetti",null,"Vaccination of children"]
[{"$nulls":4},"Vaccines"]
[{"$nulls":4},"Immunization of children"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Committee chair: Caroline Breese Hall."]
[{"$nulls":4},"Support for this project was provided by the Agency for International Development."]
[{"$nulls":4},"A summary of two workshops held September 12-13 and October 25-26, 1994."]
[null,null,"Nota di contenuto",null,"\"\"The Children's Vaccine Initiative: Continuing Activities\"\"; \"\"Copyright\"\"; \"\"Preface\"\"; \"\"Contents\"\"; \"\"Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World\"\"; \"\"INTRODUCTION\"\"; \"\"ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD\"\"; \"\"DETERMINING VACCINE NEED\"\"; \"\"OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS\"\"; \"\"Pneumococcal Vaccines\"\"; \"\"Meningococcal Vaccines\"\"; \"\"PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS\"\"; \"\"The Public-/Private-Sector Interface\"\"; \"\"INTRODUCING AN EFFECTIVE VACCINE\"\""]
[{"$nulls":4},"\"\"Involving the U.S. Public and Private Sectors in the CVI\"\"\"\"INTRODUCTION\"\"; \"\"BRINGING CLARITY TO THE CVI VISION\"\"; \"\"TRENDS IN THE GLOBAL VACCINE SITUATION\"\"; \"\"Industry Characteristics\"\"; \"\"Local Production and Self-Sufficiency\"\"; \"\"RESHAPING THE EPI\"\"; \"\"A ROLE FOR INDUSTRY\"\"; \"\"Barriers to Participation\"\"; \"\"FACILITATING GREATER U.S. INVOLVEMENT\"\"; \"\"Differential Pricing\"\"; \"\"Technology Transfer\"\"; \"\"DISCUSSION SUMMARY\"\"; \"\"Appendix A Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the "]
[{"$nulls":4},"Developing World\"\"; \"\"FINAL AGENDA\"\"; \"\"Day 1\"\"; \"\"Day 2\"\""]
[{"$nulls":4},"\"\"WORKSHOP SPEAKERS\"\"\"\"WORKSHOP PARTICIPANTS\"\"; \"\"Staff\"\"; \"\"Appendix B Involving the U.S. Public and Private Sectors in the CVI\"\"; \"\"FINAL AGENDA\"\"; \"\"Day 1\"\"; \"\"Involving the U.S. Public and Private Sectors in the CVI\"\"; \"\"WORKSHOP SPEAKERS\"\"; \"\"COMMISSIONED PAPER\"\"; \"\"WORKSHOP PARTICIPANTS\"\"; \"\"Staff\"\"; \"\"Appendix C Acronyms and Abbreviations\"\""]